M. Backonja

1.0k total citations
21 papers, 506 citations indexed

About

M. Backonja is a scholar working on Physiology, Neurology and Pharmacology. According to data from OpenAlex, M. Backonja has authored 21 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 11 papers in Neurology and 7 papers in Pharmacology. Recurrent topics in M. Backonja's work include Pain Mechanisms and Treatments (19 papers), Botulinum Toxin and Related Neurological Disorders (11 papers) and Musculoskeletal pain and rehabilitation (5 papers). M. Backonja is often cited by papers focused on Pain Mechanisms and Treatments (19 papers), Botulinum Toxin and Related Neurological Disorders (11 papers) and Musculoskeletal pain and rehabilitation (5 papers). M. Backonja collaborates with scholars based in United States, Germany and France. M. Backonja's co-authors include T. Philip Malan, Jeffrey Tobias, Geertrui F. Vanhove, Michael J. Detke, Amy S. Chappell, Vladimir Skljarevski, Satish Iyengar, Hong Liu‐Seifert, David N. Herrmann and Michael Weintraub and has published in prestigious journals such as Neurology, Pain and Journal of Hepatology.

In The Last Decade

M. Backonja

20 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Backonja United States 8 325 198 139 86 54 21 506
Dyveke Demant Denmark 5 360 1.1× 137 0.7× 194 1.4× 111 1.3× 27 0.5× 7 432
M. Stengel Germany 7 312 1.0× 164 0.8× 74 0.5× 51 0.6× 53 1.0× 11 486
Juliane Sachau Germany 11 255 0.8× 128 0.6× 88 0.6× 53 0.6× 61 1.1× 26 411
Ayelet Midbari Israel 5 246 0.8× 139 0.7× 65 0.5× 65 0.8× 26 0.5× 7 393
Malcolm Stoker Netherlands 14 690 2.1× 204 1.0× 406 2.9× 109 1.3× 56 1.0× 18 966
Jarkko Kalliomäki Sweden 12 236 0.7× 172 0.9× 50 0.4× 86 1.0× 24 0.4× 15 451
B. Cole United States 7 287 0.9× 106 0.5× 208 1.5× 33 0.4× 22 0.4× 16 437
Rohit Aiyer United States 13 167 0.5× 158 0.8× 62 0.4× 62 0.7× 56 1.0× 38 616
Dong Eon Moon South Korea 16 374 1.2× 187 0.9× 165 1.2× 35 0.4× 61 1.1× 55 750
Donglin Xiong China 13 201 0.6× 95 0.5× 51 0.4× 44 0.5× 33 0.6× 35 491

Countries citing papers authored by M. Backonja

Since Specialization
Citations

This map shows the geographic impact of M. Backonja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Backonja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Backonja more than expected).

Fields of papers citing papers by M. Backonja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Backonja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Backonja. The network helps show where M. Backonja may publish in the future.

Co-authorship network of co-authors of M. Backonja

This figure shows the co-authorship network connecting the top 25 collaborators of M. Backonja. A scholar is included among the top collaborators of M. Backonja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Backonja. M. Backonja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wasan, Ajay D., Benedict J. Alter, Robert R. Edwards, et al.. (2019). Test-Retest and Inter-Examiner Reliability of a Novel Bedside Quantitative Sensory Testing Battery in Postherpetic Neuralgia Patients. Journal of Pain. 21(7-8). 858–868. 21 indexed citations
2.
Laham, Roger J., et al.. (2015). (392) Weight change in adults with postherpetic neuralgia receiving gabapentin enacarbil in a randomized, placebo-controlled trial. Journal of Pain. 16(4). S74–S74. 2 indexed citations
3.
Freeman, Roy, Mark S. Wallace, Michael Sweeney, & M. Backonja. (2015). Relationships Among Pain Quality, Pain Impact, and Overall Improvement in Patients with Postherpetic Neuralgia Treated with Gastroretentive Gabapentin. Pain Medicine. 16(10). 2000–2011. 11 indexed citations
4.
Baron, Ralf, M. Backonja, Paul Eldridge, et al.. (2013). Refractory Chronic Pain Screening Tool (RCPST): A Feasibility Study to Assess Practicality and Validity of Identifying Potential Neurostimulation Candidates. Pain Medicine. 15(2). 281–291. 4 indexed citations
5.
Läwitz, E., Lydie Hazan, Daniel Gruener, et al.. (2012). 1189 GS-9669, A NOVEL NS5B NON-NUCLEOTIDE SITE II INHIBITOR, DEMONSTRATES POTENT ANTIVIRAL ACTIVITY, FAVORABLE SAFETY PROFILE AND POTENTIAL FOR ONCE-DAILY DOSING. Journal of Hepatology. 56. S471–S471. 5 indexed citations
6.
Backonja, M., Lynn R. Webster, Jeffrey Tobias, & Geertrui F. Vanhove. (2011). The effect of NGX-4010, a prescription strength capsaicin 8% patch, on the Neuropathic Pain Questionnaire in patients with postherpetic neuralgia. Journal of Pain. 12(4). P4–P4. 1 indexed citations
7.
8.
Backonja, M., T. Philip Malan, Geertrui F. Vanhove, & Jeffrey Tobias. (2010). NGX-4010, a High-Concentration Capsaicin Patch, for the Treatment of Postherpetic Neuralgia: A Randomized, Double-Blind, Controlled Study with an Open-Label Extension. Pain Medicine. 11(4). 600–608. 106 indexed citations
9.
Weintraub, Michael, David N. Herrmann, A. Gordon Smith, M. Backonja, & Steven P. Cole. (2009). Pulsed Electromagnetic Fields to Reduce Diabetic Neuropathic Pain and Stimulate Neuronal Repair: A Randomized Controlled Trial. Archives of Physical Medicine and Rehabilitation. 90(7). 1102–1109. 76 indexed citations
10.
11.
Attal, Nadine, M. Backonja, & Ralf Baron. (2009). 29 Topical Seminar Summary: NOVEL THERAPEUTIC OPTIONS FOR PERIPHERAL NEUROPATHIC PAIN. European Journal of Pain. 13(S1).
12.
Skljarevski, Vladimir, Hong Liu‐Seifert, Amy S. Chappell, et al.. (2009). A double‐blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. European Journal of Neurology. 16(9). 1041–1048. 128 indexed citations
13.
Hewitt, David, James A. Bolognese, Arnold R. Gammaitoni, et al.. (2009). The potential of the Enriched Enrollment Randomized Withdrawal (EERW) paradigm for proof of concept studies of novel agents for the treatment of neuropathic pain (NP). Journal of Pain. 10(4). S40–S40. 1 indexed citations
14.
Skljarevski, Vladimir, et al.. (2009). 674 MAINTENANCE OF EFFECT OF DULOXETINE IN PATIENTS WITH CHRONIC LOW BACK PAIN. European Journal of Pain. 13(S1). 3 indexed citations
15.
Blonsky, E. Richard, Jeffrey Tobias, Mark S. Wallace, et al.. (2009). Integrated analysis of efficacy and safety of NGX-4010, a high-concentration capsaicin patch, in patients with postherpetic neuralgia. Journal of Pain. 10(4). S42–S42. 1 indexed citations
16.
Ho, Tony W., et al.. (2008). Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies ☆. Pain. 141(1). 19–24. 36 indexed citations
17.
Backonja, M., et al.. (2007). Depression, Night Terrors, and Insomnia Associated With Long‐Term Intrathecal Clonidine Therapy. Pain Practice. 7(1). 36–38. 13 indexed citations
18.
Backonja, M. & Charles E. Argoff. (2005). Neuropathie Pain-Definition and Implications for Research and Therapy. 1(2). 11–17. 7 indexed citations
19.
Farrar, Jeremy, Russell K. Portenoy, Charles S. Cleeland, et al.. (2004). Opioids in non-cancer pain. Journal of Pain. 5(3). S70–S70. 1 indexed citations
20.
Wallace, Mark S., Michael C. Rowbotham, Rose Dotson, et al.. (2002). A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain. Neurology. 59(11). 1694–1700. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dyveke Demant Breakdown of academic impact, for papers by M. Stengel Breakdown of academic impact, for papers by Juliane Sachau Breakdown of academic impact, for papers by Ayelet Midbari Breakdown of academic impact, for papers by Malcolm Stoker Breakdown of academic impact, for papers by Jarkko Kalliomäki Breakdown of academic impact, for papers by B. Cole Breakdown of academic impact, for papers by Rohit Aiyer Breakdown of academic impact, for papers by Dong Eon Moon Breakdown of academic impact, for papers by Donglin Xiong
Rankless by CCL
2026